Cargando…

A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models

Treatment of tumors with Toca 511, a gamma retroviral replicating vector encoding cytosine deaminase, followed by 5-fluorocytosine (5-FC) kills tumors by local production of 5-fluorouracil (5-FU). In brain tumor models, this treatment induces systemic anti-tumor immune responses and long-term immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yagiz, Kader, Rodriguez-Aguirre, Maria E., Lopez Espinoza, Fernando, Montellano, Tiffany T., Mendoza, Daniel, Mitchell, Leah A., Ibanez, Carlos E., Kasahara, Noriyuki, Gruber, Harry E., Jolly, Douglas J., Robbins, Joan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751967/ https://www.ncbi.nlm.nih.gov/pubmed/29322091 http://dx.doi.org/10.1016/j.omto.2017.12.001

Ejemplares similares

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models
por: Mitchell, Leah A., et al.
Publicado: (2019)

Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids
por: Burnett, Ryan, et al.
Publicado: (2014)

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors (RRV) in a rodent brain tumor model
por: Yin, Dali, et al.
Publicado: (2013)

Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs
por: Vande Voorde, Johan, et al.
Publicado: (2015)

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
por: Hiraoka, Kei, et al.
Publicado: (2017)

AID/APOBEC cytosine deaminase induces genome-wide kataegis
por: Lada, Artem G, et al.
Publicado: (2012)

Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
por: Mitchell, Leah A., et al.
Publicado: (2017)

AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation
por: Nabel, Christopher S., et al.
Publicado: (2012)

Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells
por: Mesa-Pereira, Beatriz, et al.
Publicado: (2015)

Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector
por: Takahashi, Masamichi, et al.
Publicado: (2014)

Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B
por: Shi, Ke, et al.
Publicado: (2017)

Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression
por: Dubois, L, et al.
Publicado: (2007)

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
por: Ostertag, Derek, et al.
Publicado: (2012)

Adenoviral-Mediated Imaging of Gene Transfer Using a Somatostatin Receptor-Cytosine Deaminase Fusion Protein
por: Lears, Kimberly A., et al.
Publicado: (2015)

The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS
por: Niocel, Mathilde, et al.
Publicado: (2019)

A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing
por: Grünewald, Julian, et al.
Publicado: (2020)

Engineering the Active Site Lid Dynamics to Improve the Catalytic Efficiency of Yeast Cytosine Deaminase
por: Deng, Hanzhong, et al.
Publicado: (2023)

Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro
por: Lin, Amy H., et al.
Publicado: (2017)

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
por: Law, Emily K., et al.
Publicado: (2016)

Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts
por: Liu, J, et al.
Publicado: (2007)

Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells
por: Sung Park, Jin, et al.
Publicado: (2013)

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B
por: Akre, Monica K., et al.
Publicado: (2016)

Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
por: Ding, Yuedi, et al.
Publicado: (2020)

Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas
por: Zhang, Yue-Lin, et al.
Publicado: (2020)

APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A
por: Wong, Lai, et al.
Publicado: (2020)

Cytosine and adenine deaminase base-editors induce broad and nonspecific changes in gene expression and splicing
por: Fan, Jiao, et al.
Publicado: (2021)

Replication Protein A (RPA) Hampers the Processive Action of APOBEC3G Cytosine Deaminase on Single-Stranded DNA
por: Lada, Artem G., et al.
Publicado: (2011)

Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops
por: Sakhtemani, Ramin, et al.
Publicado: (2022)

Structural basis of sequence-specific cytosine deamination by double-stranded DNA deaminase toxin DddA
por: Yin, Lulu, et al.
Publicado: (2023)

Cytosine deaminase as a negative selectable marker for the microalgal chloroplast: a strategy for the isolation of nuclear mutations that affect chloroplast gene expression
por: Young, Rosanna E B, et al.
Publicado: (2014)

The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis
por: Starrett, Gabriel J., et al.
Publicado: (2016)

Connexin-43 Enhances the Redesigned Cytosine Deaminase Activity for Suicide Gene Therapy in Human Breast Cancer Cells
por: Raza, Asif, et al.
Publicado: (2019)

Aspergillus Niger thermostable Cytosine deaminase-dextran conjugates with enhanced structure stability, proteolytic resistance, and Antiproliferative activity
por: El-Sayed, Ashraf S. A., et al.
Publicado: (2023)

Dual-vector prodrug activator gene therapy using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018)

Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells
por: Biayna, Josep, et al.
Publicado: (2021)

ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
por: Kazuma, Yasuhiro, et al.
Publicado: (2022)

Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022)

Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018)

Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from Yeast
por: Mallano, Alessandra, et al.
Publicado: (2008)

Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation
por: Yamada, Suguru, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k0hb7i3c34giej837pb8uu77av